Eyepoint Pharmaceuticals

Developer of small molecule-based therapeutics for treating ophthalmic disorders

placeWatertown, Massachusetts, United States calendar_todayFounded 1987 groups49 employees language eyepointpharma.com

Registered entities

Innovation

38 patent families (26 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 3,820 times.

YearFilings
20122
20141
20162
20184
20194
20203
20216
202214
202318
202418
202512
20264

Social engagement

Social engagement: 19.5K social following, 9 posts in the last 12 months — around the industry typical range.

Investor mix

5 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital120%
Private equity120%
Other / undisclosed360%

Hiring activity

No recent openings observed

No roles tracked in the last 12 months

11 Sep 2025 · Senior Process Engineer · Northbridge

11 Sep 2025 · Engineering Technician · Northbridge

11 Sep 2025 · Lab Systems Analyst · Northbridge

Based on job postings tracked across public sources.

Recent activity

29 Jun 2026
Recognition
8 Jun 2026
Event
fireside chat at the 47th Annual Goldman Sachs Global Healthcare Conference
Coming soon